View on Pubmed.gov 36898379 | View on doi.org 10.1016/j.ccell...
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma.
- Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands. Electronic address: y.hoogstrate@erasmusmc.nl.
- Department of Neurosurgery, UMC Utrecht, 3584CX Utrecht, the Netherlands.
- Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.
- Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.
- Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Department of Precision and Microsystems Engineering, Delft University of Technology, 2628CD Delft, the Netherlands.
- Genomics Platform, GIGA Institute, Université de Liège, 4000 Liège, Belgium.
- Department of Pathology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.
- Deparment of Neuroscience, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.
- Deparment of Neuroscience, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.
- Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.
- Department of Neurology, Haaglanden Medical Center, 2512VA The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, 2333ZA Leiden, the Netherlands.
- Department of Neurology, Haaglanden Medical Center, 2512VA The Hague, the Netherlands.
- Department of Neurosurgery, Medical Center - University of Freiburg, 79106 Freiburg, Germany; Faculty of Medicine, University of Freiburg, 79085 Freiburg, Germany.
- Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.
- Department of Internal Medicine, Division of Medical Oncology, GROW, Maastricht University Medical Center, 6229ER Maastricht, the Netherlands.
- Department of Oncology, Aarhus University Hospital, 8200 Aarhus, Denmark.
- Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
- Department of Neurology, Catharina Hospital, 5623EJ Eindhoven, the Netherlands.
- Department of Pathology, Elisabeth-TweeSteden Hospital, 5042AD Tilburg, the Netherlands.
- Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2SY Birmingham, UK.
- Systems Immunity Research Institute, Medical School, Cardiff University, CF14 4XN Cardiff, UK.
- EORTC Headquarters, 1200 Brussels, Belgium.
- Université de Liège, Department of Human Genetics, 4000 Liège, Belgium.
- Department of Neurosurgery, UMC Utrecht, 3584CX Utrecht, the Netherlands; Université de Liège, Department of Human Genetics, 4000 Liège, Belgium.
- Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands. Electronic address: p.french@erasmusmc.nl.
Abstract
A better understanding of transcriptional evolution of IDH-wild-type glioblastoma may be crucial for treatment optimization. Here, we perform RNA sequencing (RNA-seq) (n = 322 test, n = 245 validation) on paired primary-recurrent glioblastoma resections of patients treated with the current standard of care. Transcriptional subtypes form an interconnected continuum in a two-dimensional space. Recurrent tumors show preferential mesenchymal progression. Over time, hallmark glioblastoma genes are not significantly altered. Instead, tumor purity decreases over time and is accompanied by co-increases in neuron and oligodendrocyte marker genes and, independently, tumor-associated macrophages. A decrease is observed in endothelial marker genes. These composition changes are confirmed by single-cell RNA-seq and immunohistochemistry. An extracellular matrix-associated gene set increases at recurrence and bulk, single-cell RNA, and immunohistochemistry indicate it is expressed mainly by pericytes. This signature is associated with significantly worse survival at recurrence. Our data demonstrate that glioblastomas evolve mainly by microenvironment (re-)organization rather than molecular evolution of tumor cells.
References
Cited by 128 citations (total)
Journal Article
Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers.
Electronic publication date February 2, 2025
Yun-Ching Chen [...] Pan-Chyr Yang et al.
Lung cancer is the most common cause of cancer mortality globally, and the prevalence of lung adenocarcinoma, the most common...
Journal Article Review
Targeting gut microbiota: a potential therapeutic approach for tumor microenvironment in glioma.
Electronic publication date April 4, 2025
Fan Qi [...] Zhaoqun Feng et al.
Glioma, being one of the malignant tumors with the highest mortality rate globally, has an unclear pathogenesis, and the existing...
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
Copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.